Il costo a carico dei pazienti del percorso per eleggibilità ai farmaci PCSK9 e follow-up di un anno: i risultati dello Studio PRIOR

BACKGROUND: Several health care services are required to get eligibility to PCSK9-inhibitors medicines and the follow-up of patients being treated. The ultimate goal is making prescriptions appropriate and monitoring the effects of these drugs. Some recent papers (opinion/consensus documents) highli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertolani, Arianna, Ravasio, Roberto, Raimondo, Paola, Jommi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768598/
https://www.ncbi.nlm.nih.gov/pubmed/36628306
http://dx.doi.org/10.33393/grhta.2022.2415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768598/
https://www.ncbi.nlm.nih.gov/pubmed/36628306
http://dx.doi.org/10.33393/grhta.2022.2415

Ejemplares similares